This Cancer Drug Is So Effective, The FDA Approved It Immediately
June 11, 2017
A new cancer drug has overwhelmingly helped shrink or eradicate tumors in patients whose cancer had resisted every other form of treatment.
The results, published in the journal Science, are so striking that the Food and Drug Administration already has approved the drug.
Image credit: Merck
The study followed 86 cancer patients with tumors of the pancreas, prostate, uterus or bone. Each patient was given pembrolizumab, which also goes by the brand name Keytruda.
After taking the drug, 66 patients had their tumors shrink substantially and stabilize, instead of continuing to grow. Among them were 18 patients whose tumors vanished and have not returned.
According to the New York Times, this is the first time a drug has been approved for use against tumors that share a particular genetic profile, regardless of where they appear in the body.
Dr. Jack Jacoub, a medical oncologist and director of thoracic oncology at Memorial Care Cancer Institute at Orange Coast Memorial Medical Center, said "The FDA doesn't take these kinds of things lightly. The data was so good, they had to approve it."
Wild Monkeys Welcome Back An Injured Young Monkey Who Spent 3 Weeks Being Treated For An Injury
Women Surround Crying Mom Whose Toddler Was Having A Meltdown At The Airport
20 Volunteers Perform CPR On Man In Grocery Store For 96 Minutes Until Paramedics Arrived
Dog Sleeps In Owners' Bed Every Night, Then They Had A Baby
The Golden Retriever Egg Challenge Is The Best Viral Video Trend Yet
Dad Comes Up With Brilliant Method To Trim Dog's Nails
Norway's Ski Team Made An Epic Parody Of 'Gangnam Style' For The 2018 Winter Olympics
Everyone Loses It Over This Game Show Question's Possible Answers
People Can't Stop Laughing At NBC's Opening Ceremony Commentary On The Netherlands
Pig Brings Lunch To His Brother Who Has Trouble Walking
This Guy Created A Highlight Reel Of His Speedy Dog Out-Maneuvering Every Other Dog At The Park